Catalyst Wire Dossier Catalyst Wire Dossier

Surface Antigen, Inactivated Influenza Vaccine Ph.Eur, Formulation 2010/2011

· Novartis Vaccines
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Surface Antigen, Inactivated Influenza Vaccine Ph.Eur, Formulation 2010/2011, covering 2021-03-10 to 2021-03-10. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011, When Administered to Adult and Elderly Subjects [Phase 3]

See pricing